PubMed Health⌕ Search

PubMed · 14524384

Pollen count forecasting.

Abstract

Pollen forecasting is becoming increasingly important to allergists as an adjunct to effective patient care. Forecasts allow patients to avoid exposure to high pollen levels and prompt them to take prophylactic medication and to plan outdoor activities for periods of low pollen levels. Investigators are making progress in developing effective models for daily and seasonal forecasts for important pollen allergens; however, current models are limited to specific geographic areas. Models for the onset of the season for spring tree pollen are based on the chilling and heat units that are required before flowering can occur. Models for pollen season severity are based on regression analysis of preseason meteorologic conditions, and models for daily forecasts are based on the normal pollen curve and responses to day-to-day meteorologic conditions. When winds are favorable, long-distance transport can introduce allergenic pollen types into a local area. The Mountain Cedar Pollen Forecasting model, which combines day-to-day release forecasts at source areas and dispersion forecasts to downwind areas, has been reasonablly successful over the past 4 years. All pollen forecasting models are dependent on accurate meteorologic forecasts, and pollen forecasting will become more accurate as meteorologic forecasts improve.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Estelle Levetin, Peter K Van de Water. 2003. Pollen count forecasting.. https://doi.org/10.1016/s0889-8561(03)00019-5

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Smallpox vaccination and myopericarditis: a clinical review.

Smallpox is a devastating viral illness that was eradicated after an aggressive, widespread vaccination campaign. Routine U.S. childhood vaccinations ended in 1972, and routine military vaccinations ended in 1990. Recently, the threat of bioterrorist use of smallpox has revived the need for vaccination. Over 450,000 U.S. military personnel received the vaccination between December 2002 and June 2003, with rates of non-cardiac complications at or below historical levels. The rate of cardiac complications, however, has been higher than expected, with two confirmed cases and over 50 probable cases of myopericarditis after vaccination reported to the Department of Defense Smallpox Vaccination Program. The practicing physician should use the history and physical, electrocardiogram, and cardiac biomarkers in the initial evaluation of a post-vaccination patient with chest pain. Echocardiogram, cardiac catheterization, magnetic resonance imaging, nuclear imaging, and cardiac biopsy may be of use in further workup. Treatment is with non-steroidal anti-inflammatory agents, four to six weeks of limited exertion, and conventional heart failure treatment as necessary. Immune suppressant therapy with steroids may be uniquely beneficial in myopericarditis related to smallpox vaccination, compared with other types of myopericarditis. If a widespread vaccination program is undertaken in the future, many more cases of post-vaccinial myopericarditis could be seen. Practicing physicians should be aware that smallpox vaccine-associated myopericarditis is a real entity, and symptoms after vaccination should be appropriately evaluated, treated if necessary, and reported to the Vaccine Adverse Events Reporting System.

Forecasting↗